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The vitamin K–dependent -glutamyl carboxylase gene contains a TATA-less
promoter with a novel upstream regulatory element
Elizabeth E. Romero, Umaima Marvi, Zachary E. Niman, and DavidA. Roth
The expression of the vitamin K–depen-
dent -glutamyl carboxylase gene in liver
is developmentally regulated. Since the
gene product catalyzes an essential post-
translational modiﬁcation of the vitamin
K–dependent blood coagulation proteins,
the regulation of carboxylase expression
is critical for hemostasis. We analyzed
the activity of the rat carboxylase gene
5-regulatory DNA sequences in rat hepa-
toma cell lines at different states of differ-
entiation. These studies demonstrated
that the 2.6-kb 5-ﬂanking sequence has
differentiation-dependent transcriptional
activity. Transient gene expression as-
says, examining the effects of nested
deletions and site-directed mutagenesis
of putative regulatory sequences, to-
gether with electrophoretic mobility shift
assays (EMSAs) were used to identify
sequences critical for the developmen-
tally regulated transcription of the rat
carboxylase gene. We identiﬁed a DNA
sequence(76to65;GTTCCGGCCTTC)
not known to bind to transcription fac-
tors, yet which functions as an upstream
promoter element. In vivo genomic DNA
footprinting conﬁrms the presence of
nuclear protein–DNA interactions at this
site in the endogenous carboxylase gene
in differentiated hepatoma cells. There-
fore, this DNA sequence has speciﬁc
nuclearprotein–bindingactivityandfunc-
tional properties consistent with a regula-
tory element that plays a critical role in
the developmental expression of the car-
boxylase gene, and hence the regulation
of vitamin K–dependent blood coagula-
tion protein synthesis. (Blood. 2003;102:
1333-1339)
© 2003 by TheAmerican Society of Hematology
Introduction
The vitamin K–dependent -glutamyl carboxylase catalyzes, in
what is the only known enzymatic reaction dependent on vitamin
K, the posttranslational modiﬁcation of glutamate to -carboxyglu-
tamate (Gla).1 Gla synthesis on vitamin K–dependent proteins
(VKDPs) in the endoplasmic reticulum2 requires vitamin K hydro-
quinone to carboxylate the -carbon of glutamate in an oxygen-
dependent reaction.1 Gla confers calcium-binding properties to all
VKDPs3 and is essential for their biologic activities.4,5 In higher
vertebrates, theVKDPs have critical functions in blood coagulation
(prothrombin, factorVII, factor IX, factor X, protein C, and protein
S), bone formation (osteocalcin), and regulation of extracellular
matrix calciﬁcation (matrix Gla protein).6-8 Gas6, a cell cycle–
regulated receptor tyrosine kinase ligand9 and 2 proline-rich
Gla-containing proteins10 are VKDPs whose in vivo activities are
not well established. Developmental activities for these VKDPs
have been hypothesized11 based on the human teratogenic effects of
warfarin, a pharmacological inhibitor of Gla synthesis.12,13 Devel-
opmental functions for Gla-containing VKDPs also have been
suggested by data developed in a chick embryogenesis model,14 in
which vitamin K–dependent signaling events appear to be critical
for orderly embryogenesis. Furthermore, mice unable to synthesize
Gla due to targeted disruption of the carboxylase gene experience
fetal demise or developmental abnormalities with features that
resemble the human warfarin embryopathy syndrome,15 indicating
that Gla synthesis is essential during mammalian development.
To determine the major sites of Gla synthesis in vivo during
mammalianembryogenesis,weexaminedcarboxylasegeneexpres-
sion in postimplantation rat embryos. Molecular analysis at the
cellular level by in situ mRNA hybridization demonstrated that at
early stages of postimplantation development, carboxylase was
expressed predominantly in the neuroectodermal tissues that be-
come the central nervous system and the mesodermal condensa-
tions that give rise to bone.11 In contrast, the carboxylase was not
detected in the endodermally derived hepatocytes until late in
development when the liver matures. The early expression of the
carboxylase in developing neural and skeletal tissues, followed by
a transition to liver in late embryogenesis, indicates that tissue-
speciﬁc control of carboxylase expression and, therefore, Gla
synthesis is developmentally regulated.
Postnatally, the liver hepatocytes are the major cellular site of
carboxylase gene expression.11 The expression of the carboxylase
gene is observed in many extrahepatic tissues, however, Northern
analyses demonstrate that the highest levels of carboxylase mRNA
are found in adult liver.11 Hepatocytes also are the major cellular
site of vitamin K–dependent blood coagulation protein synthesis.
Hence, this developmentally regulated induction of the carboxylase
gene in liver is essential for hemostatic control beginning in late
gestation. The sequences and factors that contribute to the regula-
tion of carboxylase gene expression in hepatocytes are unknown.
We therefore analyzed the promoter of the carboxylase gene to
deﬁne elements critical for its expression. We identiﬁed a DNA
sequence (GTTCCGGCCTTC) not known to be a transcription
factor binding site that functions as an upstream promoter element.
This DNAsequence binds speciﬁc nuclear proteins and is essential
From the Center for Hemostasis and Thrombosis Research, Beth Israel
Deaconess Medical Center and Harvard Medical School, Boston, MA.
Submitted December 19, 2002; acceptedApril 5, 2003. Prepublished online as
Blood First Edition Paper,April 24, 2003; DOI 10.1182/blood-2002-12-3833.
Supported by National Institutes of Health grants HL60307 and HL42443.
Reprints: David A. Roth, Beth Israel Deaconess Medical Center, 41 Avenue
Louis Pasteur, RE-302, Boston, MA02115; e-mail: droth@bidmc.harvard.edu.
The publication costs of this article were defrayed in part by page charge
payment. Therefore, and solely to indicate this fact, this article is hereby
marked ‘‘advertisement’’ in accordance with 18 U.S.C. section 1734.
© 2003 by TheAmerican Society of Hematology
1333 BLOOD, 15AUGUST 2003 VOLUME 102, NUMBER 4for carboxylase expression in cell lines that model hepatic
development.
Materials and methods
Reporter plasmids
Luciferase reporter plasmids were generated in pGL3-Basic using the
Erase-a-Base system (Promega, Madison, WI). RCBX-Luc16 was used to
produce nested deletions from the 5-end of the 5-ﬂanking sequence to
create RCBX2634 through RCBX18. The sequence of the entire insert in
RCBX2634 (2634 to 75; GenBank accession number AF159140) and
the extent of each 5 deletion were determined by automated sequencing
using oligonucleotide primers from GIBCO-BRL(Carlsbad, CA).
Polymerase chain reaction (PCR)–based mutagenesis was used to
introduce a unique BglII site immediately upstream of the insert in
RCBX64, for insertion of double-stranded oligonucleotides (Table 1) as
single or multiple copies in the forward or reverse direction. For experi-
ments that used the pGL2-promoter vector (Promega), oligonucleotides
were subcloned into the BglII site in the multiple cloning site upstream of
the SV40 early viral promoter sequence. Oligonucleotide-based site-
directed mutagenesis with sequential PCR was used to delete the 12-bp
sequence (76 to 65; GTTCCGGCCTTC) in RCBX2634 to create
RCBX2634D12 as described.17 DNA sequencing was used to conﬁrm the
accuracy of all constructs.
Transient transfection and reporter gene assays
Rat hepatoma H4IIEC3 cells were cultured as described16; dedifferentiated
rat hepatoma variant cell lines H5, HF1, C2, and C2-Rev7, all derived from
H4IIEC3, were obtained from the European Collection of Cell Cultures
(Salisbury, Wiltshire, United Kingdom) and cultured as recommended in
Coon’s Modiﬁed Ham’s F-12 (BioFluids, Rockville, MD), 2 mM
L-glutamine, 1 penicillin/streptomycin, 5% (vol/vol) fetal bovine serum
(Hyclone, Logan, UT). Transient transfection of all cell lines were
performed at a density of 40 000 cells/cm2 using lipofectin (GIBCO-BRL)
as described previously.16 To control for transfection efﬁciency, cells were
cotransfected with a control Renilla luciferase reporter plasmid (pRL-TK;
Promega). The cell extracts were prepared and assayed as described.16
Electrophoretic mobility shift assays
Nuclear extracts from cultured rat hepatoma cells were prepared as
described.18 Protein concentration was determined using the Bio-Rad
ProteinAssay (Hercules, CA) with bovine serum albumin as a standard. Rat
liver, lung, and brain nuclear extracts were obtained from Active Motif
(Carlsbad, CA). For each electrophoretic mobility shift assay (EMSA)
reaction, nuclear extract protein (5 g) and poly(dG-dC)-poly(dG-dC)
(1.25 g, Pharmacia, Uppsala, Sweden) in a total volume of 6 L was
mixed with 5 LTD (50 mM Tris [tris(hydroxymethyl)aminomethane] and
5 mM dithiothreital [DTT]) and incubated at room temperature for
60 minutes. Each reaction was then supplemented with 1 L radiolabeled
double-stranded DNA probe (1 ng/L) and incubated for an additional
15 minutes in a ﬁnal KCl concentration of 50 mM. Samples were then
supplemented with 50% (vol/vol) glycerol (3 L) and analyzed by
electrophoresis through nondenaturing 4% polyacrylamide gels in 1 TGE
pH 8.5 (25 mM Tris-Cl, 190 mM Glycine, 1.3 mM EDTA [ethylenediami-
netetraacetic acid]) at 4°C. Competition assays were performed by adding
unlabeled double-stranded oligonucleotides to the reaction during the last
15 minutes of the initial 60-minute incubation, prior to the addition of
radiolabeled probe. All double-stranded oligonucleotides were designed to
have 5-GATC overhangs after annealing, to permit subcloning or radiola-
beling with 32P-dCTP (NEN) using the large fragment of DNA
polymerase I.
In vivo genomic footprinting
Genomic dimethyl sulfate (DMS) footprinting by ligation-mediated PCR
(LM-PCR) was used to analyze the carboxylase gene in the context of
native chromatin in H4IIEC3 cells. Cells were grown to 75% conﬂuence
(300 000 cells per cm2), at which time monolayers of cells were treated with
0.1% (vol/vol) DMS for 2 minutes at 37°C to methylate DNA in vivo,
washed in phosphate-buffered saline (PBS), and immediately lysed to
isolate genomic DNA. Alternatively, untreated parallel samples of cells
were washed and lysed to isolate DNA for in vitro methylation as
described.19 In either case, methylated DNA was puriﬁed, cleaved with
piperidine, and analyzed using the following nested oligonucleotide primer
sets:reverse:5-TACCTGAGGCGGGAGCAGCT-3;5-AGCAGCTCGT-
GCAGAGCCACGGT-3;5-GCAGCTCGTGCAGAGCCACGGTGGAC-
3; forward: 5-ACTCCTTCGCTCCTGCGCAG-3;5 -GCGCAGC-
CCATCCCTAAAGCTCC-3;5-GCGCAGCCCATCCCTAAAGCTCCTC-
GC-3; unidirectional staggered linker primers were described previously.19
Radiolabeled products of in vitro and in vivo LM-PCR reactions were
analyzed following electrophoresis through 6% polyacrylamide-urea gels.
Results
Carboxylase promoter activity is dependent on hepatoma
cell line differentation
To assess whether transcriptional activity of the carboxylase gene
depends on the stage of hepatocyte differentiation, we used
transient gene expression assays to analyze carboxylase-mediated
reporter gene activity in a series of cell lines that model hepatic
development. H4IIEC3 rat hepatoma cells correspond to terminally
differentiated hepatocytes.20 They express molecular markers of
mature hepatocytes: high levels of albumin, transferrin, inducible
tyrosine aminotransferase (TAT) and alanine aminotransferase
(AAT), and gluconeogenic enzymes that permit their growth in
glucose-free medium.20 In contrast, H5, HF1 and C2 cells are
independent dedifferentiated clonal lines derived from H4IIEC3
cells.20-23 These morphologic variants lack or have signiﬁcantly
diminished expression of the aforementioned mature liver markers
and of the hepatic transcription factors associated with cell
differentiation, C/EBP, HNF-1, and HNF-4,24-26 distinguishing
them from the parental H4IIEC3 cell line. C2-Rev7, a stable
Table 1.
Oligonucleotide sequences used in the study
Name DNA Sequence
WT CTGCGGTTCCGGCCTTCACGA
A CTGCGtggCCGGCCTTCACGA
B CTGCGGTTaatGCCTTCACGA
C CTGCGGTTCCGtaaTTCACGA
D CTGCGGTTCCGGCCggaACGA
E CTGCGtgTCCGGCCTTCACGA
F CTGCGGTgaCGGCCTTCACGA
G CTGCGGTTCatGCCTTCACGA
H CTGCGGTTCCGtaCTTCACGA
I CTGCGGTTCCGGCagTCACGA
J CTGCGGTTCCGGCCTgaACGA
K CgtCGGTTCCGGCCTTCACGA
L CTGatGTTCCGGCCTTCACGA
M CTGCGGTTCCGGCCTTCcaGA
N CTGCGGTTCCGGCCTTCACtc
The sense strand sequences of the double-stranded wild-type (WT) and mutant
(Athrough N) synthetic oligonucleotides are shown and correspond to 81 to 61 in
the rat carboxylase 5-ﬂanking region. The 12-bp sequence from 76 to 65 is
indicated in bold in each of the oligonucleotide sequences. The mutated bases within
the 12-bp sequence of oligonucleotides A through J are indicated in lowercase bold
italics.The mutated bases that reside outside the 12-bp sequence of oligonucleotides
K through N are indicated in lowercase nonbold italics.
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phenotype with normal hepatocyte morphology and partially
restored liver-speciﬁc and gluconeogenic gene expression23 and
expression of the differentiation-associated hepatic transcription
factors.24,26 The transcriptional activity of the 2.6-kb 5-ﬂanking
sequence of the carboxylase gene was lowest in the most undiffer-
entiated HF1 and H5 lines (Figure 1). Carboxylase reporter gene
activity increased commensurately with markers of differentiation.
When compared with HF1 cells, a 2.2-fold increase in reporter
gene activity was seen in C2 cells that have low but measurable
basal and induced levels of TAT and AAT. A 3.8-fold increase was
observed in C2-Rev7 cells, and an 8.4-fold increase was measured
in the fully differentiated H4IIEC3 cells. These data demonstrate
that the transcriptional activity of the 2.6-kb 5-ﬂanking sequence
parallels the degree of hepatic differentiation.
An upstream promoter sequence is critical for carboxylase
reporter gene expression in H4IIEC3 cells
To identify sequences critical for promoter activity of the carboxy-
lase gene, a series of unidirectional 5-nested deletions of the
2.6-kb regulatory region were generated. The resultant reporter
plasmids were transiently transfected into the mature H4IIEC3
cells. Deletion of the DNA sequences from 2634 to 1201
resulted in a 60% loss of activity (Figure 2A). Deletion of an
additional 271 bp to 930 had no effect, while deletion to 210
restored activity to 75% of the full-length construct. Additional
deletions were analyzed to deﬁne the minimal sequences required
for activity. Deletion from 210 to 119, including an Sp1
consensus binding site (127 to 118), had no inﬂuence on
transactivation (Figure 2B), nor did deletion to 76, including a
second Sp1 site (108 to 99). In contrast, deletion of 12
additional bases (76 to 65) reduced activity from 103% to
5.7%, corresponding to a 38-fold decrease in reporter gene
expression when corrected for 3.1% background activity. RCBX64
was unable to function as a minimal promoter, despite containing
carboxylase gene sequences from 64 to 75 that include
consensus-binding sites for c-ets-1 (50 to 41) and Sp1 (13
to 4). Further deletion to 35 and 18 had no signiﬁcant effect.
The function of this 12-bp sequence from 76 to 65 was
analyzed in the context of the full-length reporter gene construct
(RCBX2634). Deletion of the 12-bp sequence resulted in a 43-fold
decrease in reporter gene activity (Figure 2C), similar to the effect
seen in the context of the minimal promoter construct. These data
demonstrate a critical function for the 12-bp sequence in the
context of both the minimal carboxylase promoter, as well as in the
context of the 2.6-kb 5-ﬂanking sequence.
Analysis of the upstream promoter element demonstrates
speciﬁc nuclear protein–DNA interactions in vitro and in vivo
The contribution of the 12-bp promoter element to reporter gene
activity suggested that these sequences bound nuclear proteins
critical for carboxylase expression. Nuclear proteins from H4IIEC3
cells were therefore used in EMSA analyses with a radiolabeled
DNA probe containing the 12-bp sequence. As demonstrated in
Figure 3A, incubation of H4IIEC3 nuclear extracts with the
Figure 3. Generation of speciﬁc H4IIEC3 nuclear protein–DNA complexes by
the sequences from 81 to 61 of the rat carboxylase gene 5-ﬂanking region.
Panel A shows cold competitor wild-type (WT) or mutant oligonucleotides with
mutations made in groups of 3 adjacent bases (A, B, C, D) were added in the molar
excesses indicated above each lane. Panel B shows cold competitor WT, B, or
mutant oligonucleotides with mutations made in groups of 2 adjacent bases (E, F, G,
H, I, J) were added in 100-fold molar excess, as indicated above each lane. Panel C
shows cold competitor WT, B, or mutant oligonucleotides with mutations made
outside the 12-bp core sequence, in groups of 2 adjacent bases (K, L, M, N), were
added in 100-fold molar excess, as indicated above each lane. The arrow in all cases
indicates the position of the upper complex referred to in “Results” and “Discussion.”
Free indicates no added nuclear protein; (), no added competitor.
Figure 1. Rat vitamin K–dependent carboxylase promoter activity in differenti-
ated and dedifferentiated rat hepatoma cell lines. The different cell lines are
indicated below the ﬁgure. Rev7 indicates C2-Rev7; H4, H4IIEC3. The average
activities shown are relative to that measured in the dedifferentiated HF1 cell line
variant, n  3. Error bars indicate SD.
Figure 2. Transcriptional activity of rat vitamin K–dependent carboxylase
mutant reporter plasmids in H4IIEC3 cells. The extent of the 5-ﬂanking sequence
contained in each reporter plasmid is indicated below the ﬁgure. (A) Reporter
plasmids RCBX2634 through RCBX210. The average normalized luciferase activity
relative to RCBX2634 is shown, n  5. Error bars  SD. (B) Reporter plasmids
RCBX210 through RCBX18. The average activity relative to RCBX210 is shown, n  5.
pGL3  pGL3-Basic without insert. (C) Deletion of the 12-bp sequence (76 to 65)
from the 2634 bp 5-ﬂanking region (D12) abolishes transcriptional activity of
RCBX2634. D12  RCBX2634D12, n  3.
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mobility. Self-competition by 10-, 50-, 100-, and 250-fold molar
excess of unlabeled WT oligonucleotide efﬁciently competed for
the generation of these complexes, demonstrating their speciﬁcity.
To deﬁne the bases essential for the formation of these complexes,
mutant double-stranded oligonucleotides (A, B, C, and D; Table 1)
were used in competition assays. Mutations were made in groups of
3 adjacent bases in the 12-bp region shown to be important for
transcriptional activity. Purines were substituted with noncomple-
mentary pyrimidines, and pyrimidines were substituted with non-
complementary purines. The mutations in oligonucleotide D mod-
erately attenuated competition for the upper complex, whereas
competition for the upper complex was abolished when mutant
oligonucleotides A, B, and C were used (Figure 3A, arrow). The
lower 2 complexes were equally competed for by all 4 mutant
oligonucleotides as shown. To further deﬁne the bases in the 12-bp
region that are required for the generation of this DNA-protein
complex, additional double-stranded mutant oligonucleotides con-
taining sequential 2-bp mutations (E, F, G, H, I, and J; Table 1)
were analyzed in competition EMSAs using 100-fold molar excess
of oligonucleotide competitors. Mutant J competed efﬁciently for
the upper complex (Figure 3B, arrow).This result is consistent with
the partial attenuation of DNA-protein binding that was previously
demonstrated with oligonucleotide D. Oligonucleotide D contains
mutations in the last 3 bases of the 12-bp sequence (T-10 to G, T-11
to G, C-12 to A). Since the same base substitutions in position 11
and 12 of oligonucleotide J have no effect on competition for the
upper complex, we conclude that the partial attenuation of DNA-
protein binding by mutations in D is due to the single substitution at
T-10. Mutations in oligonucleotides E through H also are critical
since they attenuate competition for the upper complex, similar to
what was seen with oligonucleotides A through C. Competition
EMSAs with oligonucleotides that contain sequential 2-bp muta-
tions outside the region of the 12-bp core sequence (K, L, M, and
N;Table1)revealtheyhaveactivitiessimilartotheWToligonucle-
otide (Figure 3C), demonstrating that mutations outside the 12-bp
region do not interfere with the DNA-protein interactions of the
12-bp motif. Taken together, these data demonstrate that speciﬁc
residues extending over the ﬁrst 10 bases in the 12-bp region of the
sequence are critical for the DNA-protein interactions that generate
the upper complex.
Since sequences in the 12-bp region of the wild-type DNA
probe were important for generating a speciﬁc DNA-protein
complex with nuclear extracts from well-differentiated H4IIEC3
cells, we evaluated the ability of this probe to bind proteins in
nuclear extracts from adult rat liver, as well as from dedifferenti-
ated H5 cells, and rat brain and lung to determine if the protein-
DNA interactions were restricted to cells with a mature liver
phenotype. EMSAanalysis with rat liver nuclear extract revealed a
prominentDNA-proteincomplexthatcomigratedwiththeH4IIEC3
upper complex and that had an identical competition pattern using
wild-type and mutant oligonucleotides (Figure 4A, arrow). Com-
parative EMSA analysis using the same amount of nuclear extract
from each source revealed that the upper complex was absent in the
nuclear protein extract from H5 cells and rat lung; however, a weak
signal that comigrated with the upper complex was observed with
nuclear extract from rat brain (Figure 4B, arrow). While the
expression of the factor(s) that interact with the carboxylase
upstream promoter element may not be restricted to liver, consis-
tent with low-level extrahepatic expression of the carboxylase
gene,11 the speciﬁc DNA binding activity is clearly enriched in
adult liver and in cells such as H4IIEC3 cells with a differentiated
hepatic phenotype.
To examine whether the sequences critical for the generation of
the upper complex were essential also for functional activity, we
evaluatedtheeffectofmutationsoncarboxylase-mediatedtranscrip-
tion in transient gene expression assays. One copy of the wild-type
or mutant oligonucleotides was subcloned in the forward orienta-
tion into RCBX64. Transient transfection analyses in H4IIEC3
cells demonstrated that the wild-type oligonucleotide increased the
activity of RCBX64 by 6.7-fold (Figure 5A), whereas mutant
oligonucleotides A, B, and C had no inﬂuence on transcriptional
activity, and mutant oligonucleotide D increased transcriptional
activity 2.7-fold (Figure 5A). The transcriptional activity of these
DNA sequences therefore correlates with their ability to bind the
nuclear proteins present in the upper complex on EMSA. To reﬁne
this analysis, the double-stranded mutant oligonucleotides contain-
ing sequential 2-bp mutations (E, F, G, H, I, and J; Table 1) also
were evaluated. Mutant oligonucleotides E, F, and G did not
Figure 4. Comparative EMSA analyses of nuclear extracts from H4IIEC3 cells
and adult rat liver, brain, lung and dedifferentiated H5 cells, for binding to DNA
sequences from 81 to 61 of the rat carboxylase gene 5-ﬂanking region.
Panel A shows cold competitor WT or mutant oligonucleotides (E, F, G, H, I, J) were
added in 100-fold molar excess, as indicated above each lane, in EMSAs with adult
rat liver nuclear extract. () indicates no added competitor. H4IIEC3 nuclear extract
without competitor is shown in the left lane, as indicated. The arrow indicates the
position of the upper complex referred to in “Results” and “Discussion.” Panel B
shows radiolabeled wild-type double-stranded oligonucleotide containing the 12-bp
core sequence was used in EMSA analysis with 5 g total nuclear protein in each
sample. The source of nuclear extract is indicated above each lane. The arrow
indicates the position of the speciﬁc upper complex referred to in “Results” and
“Discussion.” Free indicates no added nuclear protein.
Figure 5. Enhancement of RCBX64 transcriptional activity by double-stranded
oligonucleotides containing the 12-bp motif. A single copy of each double-
stranded oligonucleotide (Table 1) was subcloned into the BglII site of RCBX64 in the
forward direction as indicated below the ﬁgure. The transcriptional activity of each
plasmid was determined in H4IIEC3 cells. The activity is shown as the average
fold-stimulation relative to RCBX64 without an oligonucleotide (), n  3. Error bars
indicate SD. (A) WT and 3-bp mutants A through D. (B) WT and 2-bp mutants E
through J.
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tides H and I led to a 2.6-fold and 1.6-fold increase, respectively. In
contrast, transcriptional activity of mutant oligonucleotide J was
analogous to that of the wild-type sequences.The functional effects
of these 2-bp mutations, like those of the 3-bp mutations, correlated
with their ability to compete for the generation of the upper
complex in EMSAs. These data, coupled with the EMSA data,
demonstrate that the ﬁrst 10 bases in the 12-bp region GTTCCG-
GCCT (76 to 67) are critical for nuclear protein–DNA
interactions and transcriptional activity.
The effect of copy number and orientation also was evaluated in
H4IIEC3 cells. Three copies of the wild-type oligonucleotide
increased the activity of RCBX64 by 5.8-fold, whereas 6 copies
increased the activity by 9.0-fold (Figure 6A). The observed
enhancement of activity was greater than that seen with one copy of
the sequence and correlated with copy number. Multiple copies of
the oligonucleotide with mutations B or C had no signiﬁcant
inﬂuence on reporter gene expression. When the same series of
multimerized oligonucleotides was tested in the reverse orienta-
tion, a similar result was observed. To evaluate whether these
sequences could enhance transactivation by a heterologous viral
promoter, they were placed upstream to the SV40 early viral
promoter. As shown in Figure 6B, these sequences increased
reporter gene activity 2.9-fold, whereas the mutant sequence B had
no effect. These data demonstrate that the 12-bp sequence has copy
number–dependent and orientation-independent enhancement of
the carboxylase minimal promoter and is capable of enhancing
expression driven by a heterologous viral promoter.
To analyze nuclear protein–DNAinteractions in the carboxylase
promoter in the context of native chromatin, we used in vivo
footprinting to complement the functional in vitro studies described
above. The technique incorporates ligation-mediated PCR (LM-
PCR) to detect speciﬁc DMS modiﬁcations of guanine residues in
genomic DNA. Oligonucleotides were designed to analyze the
sense and antisense strands of the proximal promoter, extending
from the upstream Sp1 site (127 to 118) to the transcription
start site at 1. The guanine methylation pattern of H4IIEC3
genomic DNA exposed to DMS in vitro reveals all the guanines in
the sense strand and antisense strand of the sequence (Figure 7,
lanes 2 and 4, respectively; Figure 8). The in vivo guanine
methylation pattern of the sense strand reveals strong protection
(hypomethylation) of selected guanines (solid circles) in the
regions of each of the 3 predicted Sp1 sites (127 to 118, 108
to 99, and 13 to 4) and at residues 21 and 19 (Figure 7,
lane 1; Figure 8).While guanines at 71 and 70 within the 12-bp
sequence are not protected, enhanced methylation at guanine 76
(Figure 7, lane 1, plus sign; Figure 8) and hypomethylation at
guanine 62 are consistent with nuclear protein interactions at or
near the 5 and 3 ends of the 12-bp sequence, respectively. Partial
protection of guanines within the predicted c-ets-1 binding site
(50, 43, and 42) and 3 of this site (33, 31, and 27) also
is demonstrated in the sense strand. In vivo analysis of the antisense
strand conﬁrmed protection of residues in the 2 upstream Sp1
binding sites (Figure 7, lane 3; Figure 8). The in vivo footprint on
Figure 6. Transactivation mediated by the 12-bp enhancer is copy number
dependent and orientation independent. (A)The double-stranded oligonucleotide,
its copy number and orientation (forward, reverse) with respect to the minimal
promoter in RCBX64 () is indicated.The average activity of each reporter plasmid in
H4IIEC3 cells relative to that of RCBX64 is shown, n  3. Error bars indicate SD. (B)
The effect of the 12-bp sequence on a heterologous viral promoter in H4IIEC3 cells
was analyzed. WT indicates 1 copy of the wild type 12-bp sequence in the forward
direction; Mut, 1 copy of mutant oligonucleotide B in the forward orientation. The
average activities of these reporter plasmids are shown relative to that of the parental
minimal SV40 viral promoter vector (), n  3.
Figure 7. Ligation-mediated PCR-based in vivo genomic DNA footprinting of
the vitamin K–dependent carboxylase gene promoter in H4IIEC3 cells. Guanine
methylation patterns in the sense strand of the gene (lanes 1 and 2). Guanine
methylation patterns of the antisense strand of the gene (lanes 3 and 4). In vivo
methylation patterns of genomic DNA (lanes 1 and 3, left side of each pair of lanes)
are compared with in vitro methylation patterns (lanes 2 and 4, right side of each pair
of lanes). Relative hypomethylation of guanines in vivo is indicated with a solid dot (F).
Relative hypermethylation of guanines in vivo is indicated with a plus sign (). The
nucleotide number is indicated on the left of each footprint. The start site of
transcription at  1 is indicated with an arrow. Vertical lines indicate sequences in the
region of the 12-bp upstream promoter element.
Figure 8. Sequence of the proximal 5-ﬂanking region of the vitamin K–depen-
dent carboxylase gene. Transcription factor consensus binding sites are boxed and
labeled as indicated. UPE indicates upstream promoter element; a solid dot (F), G
hypomethylation as indicated in Figure 7; and a plus sign (), G hypermethylation as
indicated in Figure 7. Numbering is relative to the transcription start site at  1,
indicated with an arrow.
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immediately 3 of the 12-bp sequence; enhanced methylation of
guanine 68, and protection of guanine 72, each within the
12-bp sequence. The protection and enhancement of additional
guanine residues in the region of the putative c-ets-1 site and
sequences 3 of this site in the proximal promoter also are
indicated. These ﬁndings demonstrate in vivo nuclear protein–
DNA interactions in the carboxylase promoter as they occur in
H4IIEC3 cells that are actively transcribing the carboxylase gene.
Notably,theyindicatethatthegenomicDNAsequencescorrespond-
ing to the 12-bp promoter element interact with nuclear proteins,
supporting a functional in vivo role for these sequences.
Discussion
In this study, we analyzed the promoter and adjacent 5-ﬂanking
sequences of the rat carboxylase gene to identify DNA elements
that regulate its expression in differentiated hepatocytes. Using
well-characterized cell culture models of hepatocyte differentia-
tion, we demonstrated that the 2.6-kb 5-ﬂanking sequence of the
rat carboxylase gene is capable of directing reporter gene expres-
sion in a differentiation stage-speciﬁc manner, with maximal
expression activity in well-differentiated H4IIEC3 cells. This
ﬁnding parallels our previous data demonstrating that expression in
fetal rat liver increased with development.11 Data generated in the
H4IIEC3 cell line using reporter gene constructs containing
deletions and point mutations identiﬁed an upstream promoter
sequence from 76 to 65, relative to the carboxylase transcrip-
tion start site, that was essential for high-level expression in these
cells. This DNA sequence binds to nuclear proteins isolated from
the H4IIEC3 cells, and in vivo DMS footprinting conﬁrms that
nuclear protein–DNA interactions occur in this region of the
endogenous carboxylase gene in the H4IIEC3 cells. The sequence
is not only critical for the activity of the minimal carboxylase
promoter; but it also is required for the activity of the 2.6-kb
5-ﬂanking sequence in differentiated hepatoma cells. EMSAs
using the wild-type DNA probe containing the 12-bp sequence
generated a prominent nuclear protein–DNA complex when ex-
tracts from well-differentiated H4IIEC3 cells were used, and high
levels of the DNAbinding protein(s) also were detected in adult rat
liver nuclear extract. However, a prominent complex was not
observed using nuclear extracts isolated from the dedifferentiated
H5 cells, correlating with a 6-fold decrease in transactivation by
these sequences in the H5 cells. While these data indicate that
transactivation via the 12-bp upstream promoter element contrib-
utes to differentiation-dependent expression of the carboxylase in
liver cells, it is likely that additional sequences and transcription
factors contribute to the observed differences.
Variability in the expression of liver-enriched transcription
factors, regulated by and including HNF-4 and HNF-1, is in part
responsible for the variable degree of differentiation that distin-
guishes the hepatoma cell lines used in our studies.26 It has been
shown that the stable reintroduction of HNF4 in dedifferentiated
H5 cells results in only partial restoration of liver-speciﬁc gene
expression,27 with pleiotropic effects on the H5 hepatic cell
phenotype.28 Furthermore, cooperative interactions between pro-
teins that bind to regulatory regions separated by many kilobases
are known to inﬂuence developmentally regulated transcription of
liver genes. For example, the HNF3 gene is transactivated by an
HNF1 enhancer located 16 kb downstream of the promoter.
Nuclear protein–DNA interactions at this downstream enhancer
site transactivate reporter gene expression in hepatoma cells and in
developing liver in transgenic mice.29 Thus, although nuclear
protein–DNA interactions at the upstream promoter sequence
from 76 to 65 are critical for optimal transactivation by
carboxylase regulatory elements, they are unlikely to be solely
responsible for the developmentally regulated expression of the
carboxylase gene in liver cells.
In addition to remote regulatory sequences, nuclear protein–
DNA interactions in the proximal 5-ﬂanking sequence of the
carboxylase gene may also exert signiﬁcant regulatory effects on
the upstream promoter element. By analogy to other TATA-less
genes with a similar organization of the proximal promoter,
carboxylase promoter sequences that bind to basal transcription
factors are also likely to be important. However, the in vivo
interactions between basal transcription factors that regulateTATA-
less genes and factors that bind to gene speciﬁc regulatory elements
to enhance or repress their transcriptional initiation are poorly
understood. Sp1 is known to play an essential role in recruiting the
basal transcription factors to TATA-less promoters used by RNA
polymerase II.30 Since the carboxylase is a TATA-less gene with
several GC boxes in the proximal promoter region, Sp1 is likely to
be one of these important factors. Indeed, most mammalian
TATA-less promoters have one or more GC boxes in addition to
other regulatory elements upstream of the transcription start site,
implicating a central role for Sp1 in transcriptional activation of
TATA-less genes.31,32 Sp1 is believed to function via multiple
protein-protein interactions to stabilize an initiation complex and
TFIID onTATA-less promoters through a novel tethering activity.32
Alternatively, Sp1 may activate genes by interactions with cell-
speciﬁc factors, including liver-enriched factors.33 A model that
probes the mechanism of transcriptional activation by Sp1 demon-
strates the importance of upstream coactivators32 and leads us to
propose that nuclear protein–DNA interactions in the region of the
12-bp element are required for induction of carboxylase expression
by Sp1. Although in vivo footprinting of the carboxylase promoter
detected nuclear protein–DNA interactions at all 3 Sp1 sites in the
sequences studied, the 2 upstream sites were not required for
transcriptional activation in H4IIEC3 cells, pointing to a critical
role for the downstream Sp1 site. In vivo genomic footprinting
conﬁrmed nuclear protein–DNA interactions at the downstream
c-ets-1 and the Sp1 sites (50 to 41 and 13 to 4, respec-
tively), and these sites are present in the same relative locations in
other TATA-less promoters, where they are essential for their
expression.34,35 Without the 12-bp upstream promoter element,
none of these downstream sequences were able to support carboxy-
lase promoter activity. However, the difference in the transcrip-
tional activity of the upstream promoter element in its native
context (38-fold effect, Figure 2B) compared to that seen when it is
inserted, with linkers, upstream to RCBX64 (6.7-fold effect, Figure
5A) demonstrates that the precise location of the 12-bp element
relative to adjacent elements is critical for maximal transcriptional
activity. This observation suggests that the protein(s) that binds the
12-bp element may synergize with transcription factors that bind to
adjacent elements such as the Sp1 and Ets sites, which were shown
to be footprinted in the H4IIEC3 cells in vivo (Figures 7-8).
Further in vitro and in vivo studies with the carboxylase gene as
a model TATA-less promoter will provide important insights into
the function of the upstream promoter element and its role in the
transactivation of this key regulator of hemostasis. Database
analysis indicates that the sequence from 76 to 65 does not
1338 ROMERO et al BLOOD, 15AUGUST 2003 VOLUME 102, NUMBER 4containamammaliantranscriptionfactorconsensussite.36Identiﬁcation
of the factor(s) that binds this element and regulates carboxylase gene
transcription will permit us to deﬁne the consensus sequence and to
explore the aforementioned models and their relevance to other TATA-
less genes with tissue-speciﬁc developmental regulation.
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